Depressive DisordersSubstance Use Disorders (SUD)Chronic PainNeuroimaging & Brain MeasuresHealthy VolunteersSalvia Divinorum

The kappa opioid receptor and the sleep of reason: Cortico-subcortical imbalance following salvinorin-A

Acute administration of salvinorin-A, a highly selective kappa opioid receptor agonist, produced dramatic dissociative psychotomimetic effects without dysphoria and revealed a cortico–subcortical imbalance. Neurophysiologically this was reflected by widespread cortical hypoperfusion and reduced cortical EEG alpha (with increased delta and gamma) alongside increased blood flow in medial temporal regions (amygdala, hippocampal gyrus) and the cerebellum.

Authors

  • Jordi Riba
  • Gonzalo Ona
  • Marta Valle

Published

International Journal of Neuropsychopharmacology
individual Study

Abstract

Background

The mechanisms through which kappa opioid receptor (KOR) agonists induce psychotomimetic effects are largely unknown, although the modulation of this receptor has attracted attention for its clinical use. In this work, we characterize the neuropharmacological effects of salvinorin-A, a highly selective KOR agonist.

Methods

Changes in multimodal electroencephalography, single-photon emission computed tomography, and subjective effects following the acute administration of salvinorin-A are reported. The study included 2 sub-studies that employed a double-blind, crossover, randomized, placebo-controlled design.

Results

The electroencephalography measures showed a marked increase in delta and gamma waves and a decrease in alpha waves while subjects were under the effect of salvinorin-A. Regarding single-photon emission computed tomography measures, significant decreases in regional cerebral blood flow were detected in multiple regions of the frontal, temporal, parietal, and occipital cortices. Significant regional cerebral blood flow increases were observed in some regions of the medial temporal lobe, including the amygdala, the hippocampal gyrus, and the cerebellum. The pattern of subjective effects induced by salvinorin-A was similar to those observed in relation to other psychotomimetic drugs but with an evidently dissociative nature. No dysphoric effects were reported.

Conclusion

The salvinorin-A–mediated KOR agonism induced dramatic psychotomimetic effects along with a generalized decrease in cerebral blood flow and electric activity within the cerebral cortex.

Available with Blossom Pro

Research Summary of 'The kappa opioid receptor and the sleep of reason: Cortico-subcortical imbalance following salvinorin-A'

Introduction

Opioid receptors (µ, δ, and κ) were identified in the 1970s and differ in distribution, ligand selectivity, and behavioural effects. Whereas µ opioid receptor agonists produce potent analgesia accompanied by euphoria and addiction risk, kappa opioid receptor (KOR) agonists have shown analgesic, antidepressant, and neuroprotective properties but are often associated with dysphoria and psychotomimetic effects. The mechanisms that underlie KOR-induced dysphoria and the hallucinatory or psychotomimetic phenomena remain unclear. Early human investigations of KOR agonists have reported vivid alterations of perception, depersonalisation, and disturbances of space and time; together these observations suggest that KOR agonism may produce a pattern of subjective and neurophysiological effects that differs from classical serotonergic psychedelics mediated by 5-HT2A receptors. Ona and colleagues set out to characterise the functional brain changes produced by full KOR agonism using salvinorin-A, a highly selective non‑nitrogenous KOR agonist. Because salvinorin-A has a very rapid onset and brief peak effect, the investigators combined two complementary sub-studies: an EEG study (sub-study 1) to capture rapid electrophysiological dynamics, and a SPECT study (sub-study 2) to capture regional cerebral blood flow (rCBF) at the drug's peak while also collecting subjective measures. The overarching aim was to link subjective phenomenology with electrophysiological and perfusion signatures of KOR activation in healthy volunteers with prior hallucinogen experience.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

References (14)

Papers cited by this study that are also in Blossom

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms

Carhart-Harris, R. L., Roseman, L., Bolstridge, M. et al. · Scientific Reports (2017)

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)

Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion

De Araujo, D. B., Ribeiro, S., Cecchi, G. A. et al. · Human Brain Mapping (2011)

Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers

Gouzoulis-Mayfrank, E., Heekeren, K., Neukirch, A. et al. · Pharmacopsychiatry (2005)

187 cited
Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers

Kraehenmann, R., Preller, K. H., Scheidegger, M. et al. · Biological Psychiatry (2015)

Psychedelic Drugs in Biomedicine

Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R. et al. · Trends in Pharmacological Sciences (2017)

Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans

Maqueda, A. E., Valle, M., Addy, P. H. et al. · International Journal of Neuropsychopharmacology (2015)

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects

Mueller, F., Lenz, C., Dolder, P. C. et al. · Translational Psychiatry (2017)

Show all 14 references
Altered network hub connectivity after acute LSD administration

Müller, F., Dolder, P. C., Schmidt, A. et al. · NeuroImage (2018)

142 cited
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network

Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

Riba, J., Valle, M., Urbano, G. et al. · Journal of Pharmacology and Experimental Therapeutics (2003)

Neural correlates of the DMT experience assessed with multivariate EEG

Timmermann, C., Roseman, L., Schartner, M. et al. · Scientific Reports (2019)

Cited By (4)

Papers in Blossom that reference this study

Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness

Timmermann, C., Sanders, J. W., Reydellet, D. et al. · Neuroscience of Consciousness (2025)

DMT micro-phenomenology

Sanders, J. W., Milliere, R., Daily, Z. G. et al. · Preprints (2024)

Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview

Ona, G., Reverte, I., Rossi, G. N. et al. · Journal of Psychopharmacology (2023)

The Altered States Database: Psychometric data from a systematic literature review

Prugger, J., Derdiyok, E., Dinkelacker, J. et al. · Scientific Data (2022)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.